首页> 外文期刊>Chinese Journal of Clinical Oncology >Multilocular Cystic Renal Cell Carcinoma: A Series of 8 Cases and Review of the Literature
【24h】

Multilocular Cystic Renal Cell Carcinoma: A Series of 8 Cases and Review of the Literature

机译:多囊囊性肾细胞癌8例系列报道并文献复习

获取原文
获取原文并翻译 | 示例
           

摘要

OBJECTIVE To study the clinical, pathologic and imaging features of multilocular cystic renal cell carcinoma (MCRCC) and to review the diagnosis and treatment of this subtype of renal cell carcinoma (RCC). METHODS The data from 8 cases (mean age, 49.4; 5 men and 3 women) who had been treated from 2004 to 2006, were reviewed retrospectively. Radiologic and pathologic documents were evaluated. For treatments, radical nephrectomy was conducted in 4 patients, partial nephrectomy in 2 and laparoscopic nephrectomy in 2. RESULTS Postoperative pathological findings confirmed the diagnosis of MCRCC. The stage of all 8 cases was pT1. For pathologic grade, 7 cases were G1 and 1 case was G2. Seven patients available for follow-up had survived tumor-free during the mean time of 8 months. CONCLUSION MCRCC is an uncommon subtype of RCC, it has a lower malignant potential and a better prognosis compared with other types of RCC. Nephron-sparing surgery may be an appropriate treatment options for MCRCC.
机译:目的研究多发性囊性肾细胞癌(MCRCC)的临床,病理和影像学特征,并探讨该亚型肾细胞癌(RCC)的诊断和治疗。方法回顾性分析2004年至2006年收治的8例(平均年龄49.4; 5例男性和3例女性)的数据。放射学和病理学文件进行了评估。对于治疗,4例行根治性肾切除术,2例行部分肾切除术,2例行腹腔镜肾切除术。结果术后病理结果证实了MCRCC的诊断。所有8例患者的分期均为pT1。就病理分级而言,G1为7例,G2为1例。可供随访的7名患者在8个月的平均时间内无肿瘤生存。结论MCRCC是一种罕见的RCC亚型,与其他类型的RCC相比,它具有较低的恶性潜能和更好的预后。保留肾单位的手术可能是MCRCC的适当治疗选择。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号